Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection

SH Safiabadi Tali, JJ LeBlanc, Z Sadiq… - Clinical microbiology …, 2021 - Am Soc Microbiol
SUMMARY The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory disease coronavirus 2 (SARS-CoV-2), has led to millions of confirmed cases and …

The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology

BB Oude Munnink, N Worp, DF Nieuwenhuijse… - Nature medicine, 2021 - nature.com
The current coronavirus disease 2019 (COVID-19) pandemic is the first to apply whole-
genome sequencing near to real time, with over 2 million severe acute respiratory syndrome …

Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic

SW Attwood, SC Hill, DM Aanensen… - Nature Reviews …, 2022 - nature.com
Determining the transmissibility, prevalence and patterns of movement of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections is central to our understanding …

[HTML][HTML] Emergence of a new SARS-CoV-2 variant in the UK

JW Tang, PA Tambyah, DSC Hui - The Journal of infection, 2021 - ncbi.nlm.nih.gov
An earlier article described how new SARS-CoV-2 synonymous nucleotide mutations (which
had no impact on the amino acid coding) may have arisen with its move into the human …

[HTML][HTML] SARS-CoV-2 transmission between mink (Neovison vison) and humans, Denmark

AS Hammer, ML Quaade, TB Rasmussen… - Emerging infectious …, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 has caused a pandemic in humans.
Farmed mink (Neovison vison) are also susceptible. In Denmark, this virus has spread …

Immune evasion of SARS-CoV-2 emerging variants: what have we learnt so far?

I Lazarevic, V Pravica, D Miljanovic, M Cupic - Viruses, 2021 - mdpi.com
Despite the slow evolutionary rate of SARS-CoV-2 relative to other RNA viruses, its massive
and rapid transmission during the COVID-19 pandemic has enabled it to acquire significant …

[HTML][HTML] Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection

A Rahimi, A Mirzazadeh, S Tavakolpour - Genomics, 2021 - Elsevier
The outbreak of 2019-novel coronavirus disease (COVID-19), caused by SARS-CoV-2,
started in late 2019; in a short time, it has spread rapidly all over the world. Although some …

Neutralising antibody escape of SARS‐CoV‐2 spike protein: risk assessment for antibody‐based Covid‐19 therapeutics and vaccines

D Focosi, F Maggi - Reviews in medical virology, 2021 - Wiley Online Library
The Spike protein is the target of both antibody‐based therapeutics (convalescent plasma,
polyclonal serum, monoclonal antibodies) and vaccines. Mutations in Spike could affect …

[HTML][HTML] Neutralizing activity of sera from Sputnik V-vaccinated people against variants of concern (VOC: B. 1.1. 7, B. 1.351, P. 1, B. 1.617. 2, B. 1.617. 3) and Moscow …

VA Gushchin, IV Dolzhikova, AM Shchetinin… - Vaccines, 2021 - mdpi.com
Since the beginning of the 2021 year, all the main six vaccines against COVID-19 have
been used in mass vaccination companies around the world. Virus neutralization and …

[HTML][HTML] Toward a global virus genomic surveillance network

V Hill, G Githinji, CBF Vogels, AI Bento, C Chaguza… - Cell Host & Microbe, 2023 - cell.com
The COVID-19 pandemic galvanized the field of virus genomic surveillance, demonstrating
its utility for public health. Now, we must harness the momentum that led to increased …